Yan-rong Chen

Title: Yan-rong Chen: Innovator in Pharmacological Compounds

Introduction

Yan-rong Chen is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly through his innovative research and development of new compounds. With a total of 3 patents, his work has implications for the treatment of various medical conditions.

Latest Patents

One of Yan-rong Chen's latest patents involves pharmacologically active .epsilon.-valerolactams. This compound has been isolated from the leaves of Clausena lansium. The formula for this compound and its derivatives includes variations where R can be hydrogen or a C1-C18 acyl group. These compounds have been found useful in treating hypoxia and as anti-amnestic agents. Another significant patent is for 2,3-dihydroxy-3-phenyl-N-(2-phenyl-ethyl)-propionic acid amides. These compounds, also isolated from Clausena lansium, are intended for the production of compositions aimed at treating acute and chronic viral hepatitis, liver intoxication, hypoxia, or amnesia.

Career Highlights

Yan-rong Chen has worked with prestigious organizations, including the Chinese Academy of Medical Sciences and Bayer Aktiengesellschaft. His research has contributed to advancements in pharmacological applications and has garnered attention in the scientific community.

Collaborations

Some of his notable coworkers include Ming-he Yang and Geng-tao Liu. Their collaborative efforts have furthered the research and development of innovative pharmacological solutions.

Conclusion

Yan-rong Chen's contributions to pharmacology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical field positively.